```html

Yellow Eyes (Icteric Sclera)

What is Yellow Eyes (Icteric Sclera)?

Yellow eyes, medically described as icteric sclera, refer to a noticeable yellow‑tinged coloration of the white part of the eye (the sclera). The discoloration occurs when the blood level of bilirubin—a yellow pigment produced during the breakdown of red blood cells—rises above the normal range (generally >2.5 mg/dL). Bilirubin circulates in the bloodstream and deposits in tissues that have a rich blood supply, such as the skin and sclera, giving them a yellow hue.

Because the sclera is highly vascular and thin, it often reveals jaundice earlier than the skin. For many patients, the first sign that something is “off” with the liver or blood‑breaking process is a faint yellow ring around the iris. Recognizing icteric sclera promptly can lead to earlier diagnosis of potentially serious underlying conditions.

Common Causes

Yellowing of the sclera is not a disease itself but a symptom of an underlying problem that interferes with bilirubin metabolism. Below are the most frequent causes, grouped by the part of the bilirubin pathway they affect.

• Hepatocellular injury – viral hepatitis (A, B, C, E), alcoholic liver disease, non‑alcoholic fatty liver disease (NAFLD), drug‑induced liver injury.
• Bile duct obstruction – gallstones, cholangiocarcinoma, pancreatic head tumors, primary sclerosing cholangitis.
• Hemolysis (pre‑hepatic jaundice) – sickle‑cell disease, hereditary spherocytosis, autoimmune hemolytic anemia, G6PD deficiency.
• Genetic disorders of bilirubin processing – Gilbert’s syndrome, Crigler‑Najjar syndrome type I & II.
• Sepsis or severe infections – especially gram‑negative bacteremia that triggers cholestasis.
• Medication‑related cholestasis – high‑dose acetaminophen, certain antibiotics (e.g., ceftriaxone), oral contraceptives, anabolic steroids.
• Pancreatitis – inflammation can compress the distal bile duct leading to obstructive jaundice.
• Liver cancer or metastasis – hepatocellular carcinoma, metastatic lesions from colon, breast, or lung.
• Pregnancy‑related cholestasis – intrahepatic cholestasis of pregnancy (ICP) typically appears in the third trimester.
• Rare infiltrative diseases – sarcoidosis, amyloidosis, or lymphoma involving the liver.

Associated Symptoms

The presence of icteric sclera often coincides with other signs that reflect where the bilirubin overload originates. Commonly reported accompanying symptoms include:

• Yellowing of the skin (especially on the face, neck, and palms)
• Dark urine (bilirubin‑stained, “tea‑colored”)
• Clay‑colored stools (absence of stercobilin)
• Pruritus (intense itching) due to bile salt deposition
• Upper right abdominal pain or a feeling of fullness
• Fatigue, weakness, or malaise
• Fever or chills (suggesting infection or cholangitis)
• Nausea, vomiting, or loss of appetite
• Weight loss (particularly with malignancy)
• Joint or bone pain (seen in hemolytic anemias)

When to See a Doctor

Yellow sclera should never be ignored, especially when it appears suddenly or is accompanied by other concerning signs. Seek medical attention promptly if you notice:

• Rapid progression of yellowing over a few days
• Severe abdominal pain, especially in the upper right quadrant
• Fever above 100.4 °F (38 °C) with chills
• Persistent vomiting, confusion, or altered mental status
• Dark urine combined with pale or gray stools
• Unexplained weight loss or loss of appetite lasting >2 weeks
• Itching that interferes with sleep or daily activities
• History of liver disease, heavy alcohol use, or recent medication changes

Diagnosis

Evaluating icteric sclera involves a systematic approach to pinpoint the source of excess bilirubin.

History & Physical Examination

• Detailed medication, alcohol, and travel history
• Family history of liver or blood disorders
• Physical exam focusing on liver span, tenderness, splenomegaly, and signs of chronic liver disease (spider angiomas, palmar erythema)

Laboratory Tests

• Serum bilirubin panel – total, direct (conjugated) and indirect (unconjugated) bilirubin levels.
• Liver function tests (LFTs) – ALT, AST, ALP, GGT, albumin, and prothrombin time/INR.
• Complete blood count (CBC) – looks for anemia, leukocytosis, or thrombocytopenia.
• Hemolysis work‑up – LDH, haptoglobin, reticulocyte count, peripheral smear.
• Viral hepatitis serologies – HBsAg, anti‑HBc, anti‑HCV, HAV IgM.
• Autoimmune markers – ANA, ASMA, anti‑LKM1 when autoimmune hepatitis is suspected.
• Metabolic panels – fasting glucose, lipid profile (relevant for NAFLD).

Imaging Studies

• Abdominal ultrasound – first‑line to assess gallbladder stones, biliary duct dilation, liver texture.
• CT or MRI of the abdomen – detailed evaluation of masses, pancreatic lesions, or cholangiocarcinoma.
• Magnetic resonance cholangiopancreatography (MRCP) – non‑invasive view of the biliary tree.
• Endoscopic retrograde cholangiopancreatography (ERCP) – both diagnostic and therapeutic for obstructive causes.

Special Tests

• Hepatobiliary iminodiacetic acid (HIDA) scan – assesses bile flow when obstruction is uncertain.
• Genetic testing for Gilbert’s or Crigler‑Najjar syndromes when unexplained unconjugated hyperbilirubinemia persists.

Treatment Options

Treatment is directed at the underlying cause. Below are typical management strategies based on etiology.

1. Hepatocellular Injury

• Viral hepatitis – antiviral agents (e.g., entecavir, tenofovir for HBV; direct‑acting antivirals for HCV), supportive care, and vaccination for HAV.
• Alcoholic liver disease – abstinence from alcohol, nutritional support (high‑protein diet, vitamin B1), and in severe cases, corticosteroids or liver transplantation.
• NAFLD/NASH – weight loss (7‑10 % of body weight), exercise, insulin‑sensitizing agents (pioglitazone), and Vitamin E in selected non‑diabetic patients.

2. Biliary Obstruction

• Endoscopic stone extraction (ERCP) for choledocholithiasis.
• Surgical removal or stenting of tumors causing obstruction.
• Ursodeoxycholic acid (UDCA) for primary biliary cholangitis.

3. Hemolytic Disorders

• Treat underlying cause – e.g., hydroxyurea for sickle‑cell disease, avoidance of oxidative drugs in G6PD deficiency.
• Transfusion support if severe anemia.
• Folic acid supplementation to support increased erythropoiesis.

4. Genetic Syndromes

• Gilbert’s syndrome – usually requires no treatment; patient education about fasting and stress avoidance.
• Crigler‑Najjar type I – phototherapy in neonates, liver transplantation is definitive.

5. Symptomatic Relief

• Antihistamines or cholestyramine for pruritus.
• Hydration and a low‑fat diet to reduce bilirubin load.
• Vitamin K supplementation if coagulopathy is present.

6. Home Care Measures

• Stay well‑hydrated (aim for ≥2 L water daily).
• Limit alcohol and high‑fat meals.
• Maintain a balanced diet rich in fruits, vegetables, and lean protein.
• Keep a symptom diary to track changes and share with your clinician.

Prevention Tips

While not all causes of icteric sclera are preventable, many risk factors are modifiable.

• Vaccinate against hepatitis A and B.
• Limit alcohol consumption – no more than 1 drink per day for women and 2 for men.
• Maintain a healthy weight (< 25 kg/m²) to reduce NAFLD risk.
• Practice safe sex and avoid sharing needles to prevent viral hepatitis.
• Use medications as prescribed; discuss any new over‑the‑counter drugs with your clinician.
• Stay up‑to‑date on regular health screenings (liver function tests if you have risk factors).
• For those with known hemolytic disorders, avoid triggers (e.g., certain foods, infections, certain drugs).
• Pregnant women should report any new itching or yellowing promptly to obstetric care providers to catch intra‑hepatic cholestasis early.

Emergency Warning Signs

If you experience any of the following, seek emergency care (ER or call 911) immediately:

• Sudden, severe abdominal pain especially with fever – possible cholangitis or gallbladder perforation.
• Confusion, drowsiness, or difficulty staying awake – may indicate hepatic encephalopathy.
• Rapidly worsening jaundice accompanied by vomiting blood or black stools – sign of gastrointestinal bleeding.
• Sudden swelling of the abdomen (ascites) with shortness of breath.
• High‑grade fever (> 102 °F or 38.9 °C) with chills and rigors.

---

**References**

• Mayo Clinic. “Jaundice.” Accessed March 2024.
• American Liver Foundation. “Understanding Liver Test Results.” Accessed March 2024.
• National Institutes of Health (NIH). “Bilirubin Metabolism.” Accessed March 2024.
• World Health Organization. “Hepatitis.” Accessed March 2024.
• Cleveland Clinic. “Causes of Jaundice.” Accessed March 2024.
• UpToDate. “Evaluation of the patient with jaundice.” (subscription required). 2024.

```